Ampersand Capital Partners acquires MedPharm Ltd

On March 26, 2018, Ampersand Capital Partners acquired MedPharm Ltd, a life science company in United Kingdom.

Deal at a glance

AnnouncedMarch 26, 2018 TypeAdd-on Acquistion TargetMedPharm Ltd Buyer Ampersand Capital Partners SectorLife Science LocationUnited Kingdom ValueNot disclosed

Target company

MedPharm Ltd

United Kingdom

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Ampersand Capital Partners

Private equity firm · 76 deals on record

15th transaction in life science
1st transaction in United Kingdom

76deals, all time

32in this sector

2022latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Syft Technologies Ltd.Same lead buyer · Apr 2022

BioEcho Life Sciences GmbHSame lead buyer · Mar 2022

Drug Development SolutionsSame sector and country · May 2022

Aptus Clinical Ltd.Same sector and country · May 2022

Panthera BiopartnersSame sector and country · Apr 2022

Questions about this deal

Who acquired MedPharm Ltd?Ampersand Capital Partners acquired MedPharm Ltd on March 26, 2018.

What type of deal was it?It was a add-on acquistion in the life science sector in 2018.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).